From Optimized Monovalent Ligands to Size-Controlled Dendrimers: An Efficient Strategy Towards High-Activity DC-SIGN Antagonists
Canadian Journal of Chemistry - Canada
doi 10.1139/cjc-2017-0138
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2017
Authors
Publisher
Canadian Science Publishing